A 0 1 0 1 O
single 2 8 2 8 O
, 8 9 8 9 O
biopsy 10 16 10 16 B-treatment
- 16 17 16 17 O
proven 17 23 17 23 O
SISCCA 24 30 24 30 B-cancer
as 31 33 31 33 O
defined 34 41 34 41 O
by 42 44 42 44 O
the 45 48 45 48 O
LAST 49 53 49 53 B-clinical_variable
criteria 54 62 54 62 I-clinical_variable
(= 63 65 63 65 O
< 65 66 65 66 O
3 67 68 67 68 B-upper_bound
mm 68 70 68 70 I-upper_bound
depth 71 76 71 76 I-upper_bound
of 77 79 77 79 I-upper_bound
invasion 80 88 80 88 I-upper_bound
, 88 89 88 89 O
horizontal 90 100 90 100 B-clinical_variable
spread 101 107 101 107 I-clinical_variable
of 108 110 108 110 O
= 111 112 111 112 O
< 112 113 112 113 O
7 114 115 114 115 B-upper_bound
mm 116 118 116 118 I-upper_bound
, 118 119 118 119 O
and 120 123 120 123 O
completely 124 134 124 134 O
excised 135 142 135 142 O
with 143 147 143 147 O
at 148 150 148 150 O
least 151 156 151 156 O
1 157 158 157 158 B-lower_bound
mm 159 161 159 161 I-lower_bound
margin 162 168 162 168 I-lower_bound
clear 169 174 169 174 O
of 175 177 175 177 O
cancer 178 184 178 184 B-cancer
irrespective 185 197 185 197 O
of 198 200 198 200 O
the 201 204 201 204 O
amount 205 211 205 211 O
of 212 214 212 214 O
HSIL 215 219 215 219 O
) 219 220 219 220 O
documented 221 231 221 231 O
within 232 238 232 238 O
8 239 240 239 240 B-upper_bound
weeks 241 246 241 246 I-upper_bound
of 247 249 247 249 O
enrollment 250 260 250 260 O

Acute 0 5 261 266 O
treatment 6 15 267 276 B-treatment
for 16 19 277 280 O
an 20 22 281 283 O
infection 23 32 284 293 B-chronic_disease
( 33 34 294 295 O
excluding 34 43 295 304 O
fungal 44 50 305 311 B-chronic_disease
infection 51 60 312 321 I-chronic_disease
of 61 63 322 324 I-chronic_disease
the 64 67 325 328 I-chronic_disease
skin 68 72 329 333 I-chronic_disease
and 73 76 334 337 O
sexually 77 85 338 346 B-chronic_disease
transmitted 86 97 347 358 I-chronic_disease
infections 98 108 359 369 I-chronic_disease
) 108 109 369 370 O
or 110 112 371 373 O
other 113 118 374 379 O
serious 119 126 380 387 O
medical 127 134 388 395 O
illness 135 142 396 403 O
within 143 149 404 410 O
2 150 151 411 412 B-upper_bound
weeks 152 157 413 418 I-upper_bound
before 158 164 419 425 I-upper_bound
enrollment 165 175 426 436 O

Anal 0 4 437 441 B-cancer
cancer 5 11 442 448 I-cancer
that 12 16 449 453 O
can 17 20 454 457 O
not 20 23 457 460 O
be 24 26 461 463 O
completely 27 37 464 474 O
excised 38 45 475 482 O
with 46 50 483 487 O
a 51 52 488 489 O
> 53 54 490 491 O
= 54 55 491 492 O
1 55 56 492 493 B-lower_bound
mm 57 59 494 496 I-lower_bound
clear 60 65 497 502 O
margin 66 72 503 509 O
from 73 77 510 514 O
surrounding 78 89 515 526 O
tissue 90 96 527 533 O
or 97 99 534 536 O
where 100 105 537 542 O
excision 106 114 543 551 O
to 115 117 552 554 O
obtain 118 124 555 561 O
a 125 126 562 563 O
clear 127 132 564 569 O
margin 133 139 570 576 O
would 140 145 577 582 O
compromise 146 156 583 593 O
sphincter 157 166 594 603 O
function 167 175 604 612 O
or 176 178 613 615 O
anal 179 183 616 620 O
canal 184 189 621 626 O
diameter 190 198 627 635 O

Concurrent 0 10 636 646 O
anal 11 15 647 651 O
canal 16 21 652 657 B-cancer
or 22 24 658 660 O
perianal 25 33 661 669 B-chronic_disease
HSIL 34 38 670 674 I-chronic_disease
or 39 41 675 677 O
condyloma 42 51 678 687 B-chronic_disease
that 52 56 688 692 O
in 57 59 693 695 O
the 60 63 696 699 O
judgment 64 72 700 708 O
of 73 75 709 711 O
the 76 79 712 715 O
clinician 80 89 716 725 O
can 90 93 726 729 O
not 93 96 729 732 O
be 97 99 733 735 O
cleared 100 107 736 743 O
or 108 110 744 746 O
can 111 114 747 750 O
only 115 119 751 755 O
be 120 122 756 758 O
cleared 123 130 759 766 O
with 131 135 767 771 O
undue 136 141 772 777 O
morbidity 142 151 778 787 O
to 152 154 788 790 O
the 155 158 791 794 O
patient 159 166 795 802 O

Current 0 7 803 810 O
systemic 8 16 811 819 B-treatment
chemotherapy 17 29 820 832 I-treatment
or 30 32 833 835 O
radiation 33 42 836 845 B-treatment
therapy 43 50 846 853 I-treatment
that 51 55 854 858 O
potentially 56 67 859 870 O
causes 68 74 871 877 O
bone 75 79 878 882 O
marrow 80 86 883 889 O
suppression 87 98 890 901 O
that 99 103 902 906 O
would 104 109 907 912 O
preclude 110 118 913 921 O
safe 119 123 922 926 B-treatment
treatment 124 133 927 936 I-treatment
of 134 136 937 939 O
HSIL 137 141 940 944 O

HIV-1 0 5 945 950 B-chronic_disease
infection 6 15 951 960 I-chronic_disease
, 15 16 960 961 O
as 17 19 962 964 O
documented 20 30 965 975 O
by 31 33 976 978 O
any 34 37 979 982 O
federally 38 47 983 992 O
approved 48 56 993 1001 O
, 56 57 1001 1002 O
licensed 58 66 1003 1011 O
HIV 67 70 1012 1015 O
test 71 75 1016 1020 O
performed 76 85 1021 1030 O
in 86 88 1031 1033 O
conjunction 89 100 1034 1045 O
with 101 105 1046 1050 O
screening 106 115 1051 1060 O
( 116 117 1061 1062 O
or 117 119 1062 1064 O
enzyme 120 126 1065 1071 B-treatment
- 126 127 1071 1072 I-treatment
linked 127 133 1072 1078 I-treatment
immunosorbent 134 147 1079 1092 I-treatment
assay 148 153 1093 1098 I-treatment
[ 154 155 1099 1100 I-treatment
ELISA 155 160 1100 1105 I-treatment
] 160 161 1105 1106 I-treatment
, 161 162 1106 1107 O
test 163 167 1108 1112 O
kit 168 171 1113 1116 O
, 171 172 1116 1117 O
and 173 176 1118 1121 O
confirmed 177 186 1122 1131 O
by 187 189 1132 1134 O
Western 190 197 1135 1142 O
blot 198 202 1143 1147 O
or 203 205 1148 1150 O
other 206 211 1151 1156 O
approved 212 220 1157 1165 O
test 221 225 1166 1170 O
) 225 226 1170 1171 O
; 226 227 1171 1172 O
alternatively 228 241 1173 1186 O
, 241 242 1186 1187 O
this 243 247 1188 1192 O
documentation 248 261 1193 1206 O
may 262 265 1207 1210 O
include 266 273 1211 1218 O
a 274 275 1219 1220 O
record 276 282 1221 1227 O
demonstrating 283 296 1228 1241 O
that 297 301 1242 1246 O
another 302 309 1247 1254 O
physician 310 319 1255 1264 O
has 320 323 1265 1268 O
documented 324 334 1269 1279 O
the 335 338 1280 1283 O
participant 339 350 1284 1295 O
's 350 352 1295 1297 O
HIV 353 356 1298 1301 O
status 357 363 1302 1308 O
based 364 369 1309 1314 O
on 370 372 1315 1317 O
either 373 379 1318 1324 O
: 379 380 1324 1325 O
1 381 382 1326 1327 O
) 382 383 1327 1328 O
approved 384 392 1329 1337 O
diagnostic 393 403 1338 1348 O
tests 404 409 1349 1354 O
or 410 412 1355 1357 O
2 413 414 1358 1359 O
) 414 415 1359 1360 O
relevant 416 424 1361 1369 O
medical 425 432 1370 1377 O
history 433 440 1378 1385 O
and/or 441 447 1386 1392 O
current 448 455 1393 1400 O
management 456 466 1401 1411 O
of 467 469 1412 1414 O
HIV 470 473 1415 1418 B-chronic_disease
infection 474 483 1419 1428 I-chronic_disease

Leukocytes 0 10 1429 1439 B-clinical_variable
: 10 11 1439 1440 O
> 12 13 1441 1442 O
= 13 14 1442 1443 O
3,000 15 20 1444 1449 B-lower_bound
/ 20 21 1449 1450 I-lower_bound
mm^3 21 25 1450 1454 I-lower_bound

No 0 2 1455 1457 O
evidence 3 11 1458 1466 O
of 12 14 1467 1469 O
any 15 18 1470 1473 O
lymph 19 24 1474 1479 B-cancer
node 25 29 1480 1484 I-cancer
spread 30 36 1485 1491 I-cancer
or 37 39 1492 1494 O
distant 40 47 1495 1502 B-cancer
metastases 48 58 1503 1513 I-cancer
as 59 61 1514 1516 O
determined 62 72 1517 1527 O
by 73 75 1528 1530 O
positron 76 84 1531 1539 B-treatment
emission 85 93 1540 1548 I-treatment
tomography 94 104 1549 1559 I-treatment
( 105 106 1560 1561 I-treatment
PET 106 109 1561 1564 I-treatment
) 109 110 1564 1565 I-treatment
computed 111 119 1566 1574 B-treatment
tomography 120 130 1575 1585 I-treatment
( 131 132 1586 1587 I-treatment
CT 132 134 1587 1589 I-treatment
) 134 135 1589 1590 I-treatment
imaging 136 143 1591 1598 I-treatment
within 144 150 1599 1605 O
8 151 152 1606 1607 B-upper_bound
weeks 153 158 1608 1613 I-upper_bound
of 159 161 1614 1616 O
enrollment 162 172 1617 1627 O

Ongoing 0 7 1628 1635 O
use 8 11 1636 1639 O
of 12 14 1640 1642 O
anticoagulant 15 28 1643 1656 B-treatment
therapy 29 36 1657 1664 I-treatment
other 37 42 1665 1670 O
than 43 47 1671 1675 O
aspirin 48 55 1676 1683 B-treatment
or 56 58 1684 1686 O
non 59 62 1687 1690 B-treatment
- 62 63 1690 1691 I-treatment
steroidal 63 72 1691 1700 I-treatment
anti 73 77 1701 1705 I-treatment
- 77 78 1705 1706 I-treatment
inflammatory 78 90 1706 1718 I-treatment
drugs 91 96 1719 1724 I-treatment
( 97 98 1725 1726 I-treatment
NSAIDS 98 104 1726 1732 I-treatment
) 104 105 1732 1733 I-treatment
that 106 110 1734 1738 O
can 111 114 1739 1742 O
not 114 117 1742 1745 O
be 118 120 1746 1748 O
stopped 121 128 1749 1756 O
for 129 132 1757 1760 O
surgical 133 141 1761 1769 B-treatment
procedures 142 152 1770 1780 I-treatment

Participants 0 12 1781 1793 O
must 13 17 1794 1798 O
have 18 22 1799 1803 O
Eastern 23 30 1804 1811 B-clinical_variable
Cooperative 31 42 1812 1823 I-clinical_variable
Oncology 43 51 1824 1832 I-clinical_variable
Group 52 57 1833 1838 I-clinical_variable
( 58 59 1839 1840 I-clinical_variable
ECOG 59 63 1840 1844 I-clinical_variable
) 63 64 1844 1845 I-clinical_variable
performance 65 76 1846 1857 I-clinical_variable
status 77 83 1858 1864 I-clinical_variable
0 84 85 1865 1866 B-lower_bound
- 85 86 1866 1867 O
2 86 87 1867 1868 B-upper_bound

Participants 0 12 1869 1881 O
must 13 17 1882 1886 O
have 18 22 1887 1891 O
a 23 24 1892 1893 O
life 25 29 1894 1898 B-clinical_variable
expectancy 30 40 1899 1909 I-clinical_variable
of 41 43 1910 1912 O
2 44 45 1913 1914 B-lower_bound
years 46 51 1915 1920 I-lower_bound
or 52 54 1921 1923 O
more 55 59 1924 1928 O

Participants 0 12 1929 1941 O
must 13 17 1942 1946 O
not 18 21 1947 1950 O
have 22 26 1951 1955 O
any 27 30 1956 1959 O
other 31 36 1960 1965 O
concurrent 37 47 1966 1976 O
malignancy 48 58 1977 1987 B-cancer

Patients 0 8 1988 1996 O
who 9 12 1997 2000 O
are 13 16 2001 2004 O
receiving 17 26 2005 2014 O
any 27 30 2015 2018 O
other 31 36 2019 2024 O
investigational 37 52 2025 2040 B-treatment
agents 53 59 2041 2047 I-treatment
within 60 66 2048 2054 O
4 67 68 2055 2056 B-upper_bound
weeks 69 74 2057 2062 I-upper_bound
prior 75 80 2063 2068 I-upper_bound
to 81 83 2069 2071 O
enrollment 84 94 2072 2082 O
; 94 95 2082 2083 O
investigational 96 111 2084 2099 B-treatment
antiretroviral 112 126 2100 2114 I-treatment
agents 127 133 2115 2121 I-treatment
for 134 137 2122 2125 O
HIV 138 141 2126 2129 B-chronic_disease
are 142 145 2130 2133 O
acceptable 146 156 2134 2144 O

Prior 0 5 2145 2150 B-treatment
HPV 6 9 2151 2154 I-treatment
vaccination 10 21 2155 2166 I-treatment

Prior 0 5 2167 2172 B-treatment
pelvic 6 12 2173 2179 I-treatment
radiation 13 22 2180 2189 I-treatment
therapy 23 30 2190 2197 I-treatment
that 31 35 2198 2202 O
would 36 41 2203 2208 O
preclude 42 50 2209 2217 O
radiation 51 60 2218 2227 O
therapy 61 68 2228 2235 O
if 69 71 2236 2238 O
anal 72 76 2239 2243 B-cancer
cancer 77 83 2244 2250 I-cancer
develops 84 92 2251 2259 O

Prior 0 5 2260 2265 O
to 6 8 2266 2268 O
Segment 9 16 2269 2276 O
A 17 18 2277 2278 O
enrollment 19 29 2279 2289 O
, 29 30 2289 2290 O
patients 31 39 2291 2299 O
on 40 42 2300 2302 O
combination 43 54 2303 2314 B-treatment
anti 55 59 2315 2319 I-treatment
- 59 60 2319 2320 I-treatment
retroviral 60 70 2320 2330 I-treatment
therapy 71 78 2331 2338 I-treatment
( 79 80 2339 2340 I-treatment
cART 80 84 2340 2344 I-treatment
) 84 85 2344 2345 I-treatment
will 86 90 2346 2350 O
be 91 93 2351 2353 O
required 94 102 2354 2362 O
to 103 105 2363 2365 O
have 106 110 2366 2370 O
a 111 112 2371 2372 O
minimum 113 120 2373 2380 O
cluster 121 128 2381 2388 O
of 129 131 2389 2391 O
differentiation 132 147 2392 2407 O
( 148 149 2408 2409 B-clinical_variable
CD)4 149 153 2409 2413 I-clinical_variable
count 154 159 2414 2419 I-clinical_variable
of 160 162 2420 2422 O
> 163 164 2423 2424 O
= 164 165 2424 2425 O
200 166 169 2426 2429 B-lower_bound
and 170 173 2430 2433 O
patients 174 182 2434 2442 O
not 183 186 2443 2446 O
on 187 189 2447 2449 O
cART 190 194 2450 2454 O
will 195 199 2455 2459 O
be 200 202 2460 2462 O
required 203 211 2463 2471 O
to 212 214 2472 2474 O
have 215 219 2475 2479 O
a 220 221 2480 2481 O
minimum 222 229 2482 2489 O
CD4 230 233 2490 2493 B-clinical_variable
count 234 239 2494 2499 I-clinical_variable
of 240 242 2500 2502 O
> 243 244 2503 2504 O
= 244 245 2504 2505 O
350 245 248 2505 2508 B-lower_bound
to 249 251 2509 2511 O
be 252 254 2512 2514 O
eligible 255 263 2515 2523 O
for 264 267 2524 2527 O
the 268 271 2528 2531 O
study 272 277 2532 2537 O
; 277 278 2537 2538 O
patients 279 287 2539 2547 O
not 288 291 2548 2551 O
currently 292 301 2552 2561 O
on 302 304 2562 2564 O
cART 305 309 2565 2569 O
who 310 313 2570 2573 O
have 314 318 2574 2578 O
a 319 320 2579 2580 O
CD4 321 324 2581 2584 O
count 325 330 2585 2590 O
> 331 332 2591 2592 O
200 333 336 2593 2596 O
and 337 340 2597 2600 O
who 341 344 2601 2604 O
agree 345 350 2605 2610 O
to 351 353 2611 2613 O
start 354 359 2614 2619 O
cART 360 364 2620 2624 O
immediately 365 376 2625 2636 O
will 377 381 2637 2641 O
be 382 384 2642 2644 O
eligible 385 393 2645 2653 O
for 394 397 2654 2657 O
participation 398 411 2658 2671 O
; 411 412 2671 2672 O
laboratory 413 423 2673 2683 O
data 424 428 2684 2688 O
should 429 435 2689 2695 O
be 436 438 2696 2698 O
obtained 439 447 2699 2707 O
within 448 454 2708 2714 O
12 455 457 2715 2717 B-upper_bound
weeks 458 463 2718 2723 I-upper_bound
prior 464 469 2724 2729 I-upper_bound
to 470 472 2730 2732 O
enrollment 473 483 2733 2743 O

Women 0 5 2744 2749 B-gender
of 6 8 2750 2752 O
childbearing 9 21 2753 2765 O
potential 22 31 2766 2775 O
must 32 36 2776 2780 O
have 37 41 2781 2785 O
a 42 43 2786 2787 O
negative 44 52 2788 2796 B-pregnancy
urine 53 58 2797 2802 I-pregnancy
pregnancy 59 68 2803 2812 I-pregnancy
test 69 73 2813 2817 O
within 74 80 2818 2824 O
72 81 83 2825 2827 B-upper_bound
hours 84 89 2828 2833 I-upper_bound
prior 90 95 2834 2839 I-upper_bound
to 96 98 2840 2842 O
enrollment 99 109 2843 2853 O

all 0 3 2854 2857 O
women 4 9 2858 2863 B-gender
of 10 12 2864 2866 O
childbearing 13 25 2867 2879 O
potential 26 35 2880 2889 O
must 36 40 2890 2894 O
agree 41 46 2895 2900 B-contraception_consent
to 47 49 2901 2903 I-contraception_consent
use 50 53 2904 2907 I-contraception_consent
a 54 55 2908 2909 I-contraception_consent
reliable 56 64 2910 2918 I-contraception_consent
birth 65 70 2919 2924 I-contraception_consent
control 71 78 2925 2932 I-contraception_consent
method 79 85 2933 2939 I-contraception_consent
( 86 87 2940 2941 O
oral 87 91 2941 2945 B-contraception_consent
contraceptive 92 105 2946 2959 I-contraception_consent
pills 106 111 2960 2965 I-contraception_consent
, 111 112 2965 2966 O
intrauterine 113 125 2967 2979 B-contraception_consent
device 126 132 2980 2986 I-contraception_consent
, 132 133 2986 2987 O
Nexplanon 134 143 2988 2997 B-contraception_consent
, 143 144 2997 2998 O
DepoProvera 145 156 2999 3010 B-contraception_consent
, 156 157 3010 3011 O
or 158 160 3012 3014 O
permanent 161 170 3015 3024 B-contraception_consent
sterilization 171 184 3025 3038 I-contraception_consent
, 184 185 3038 3039 O
etc 186 189 3040 3043 O
. 189 190 3043 3044 O
, 190 191 3044 3045 O
or 192 194 3046 3048 O
another 195 202 3049 3056 O
acceptable 203 213 3057 3067 O
method 214 220 3068 3074 O
as 221 223 3075 3077 O
determined 224 234 3078 3088 O
by 235 237 3089 3091 O
the 238 241 3092 3095 O
investigator 242 254 3096 3108 O
) 254 255 3108 3109 O
during 256 262 3110 3116 O
the 263 266 3117 3120 O
entire 267 273 3121 3127 O
period 274 280 3128 3134 O
of 281 283 3135 3137 O
the 284 287 3138 3141 O
trial 288 293 3142 3147 O
( 294 295 3148 3149 O
3 295 296 3149 3150 B-upper_bound
years 297 302 3151 3156 I-upper_bound
) 302 303 3156 3157 O
, 303 304 3157 3158 O
and 305 308 3159 3162 O
must 309 313 3163 3167 O
not 314 317 3168 3171 O
intend 318 324 3172 3178 O
to 325 327 3179 3181 O
become 328 334 3182 3188 B-pregnancy
pregnant 335 343 3189 3197 I-pregnancy
during 344 350 3198 3204 O
study 351 356 3205 3210 O
participation 357 370 3211 3224 O
and 371 374 3225 3228 O
for 375 378 3229 3232 O
3 379 380 3233 3234 B-upper_bound
months 381 387 3235 3241 I-upper_bound
after 388 393 3242 3247 I-upper_bound
treatment 394 403 3248 3257 B-treatment
is 404 406 3258 3260 O
discontinued 407 419 3261 3273 O

alternatively 0 13 3274 3287 O
for 14 17 3288 3291 O
those 18 23 3292 3297 O
without 24 31 3298 3305 O
PET 32 35 3306 3309 B-treatment
CT 36 38 3310 3312 I-treatment
capability 39 49 3313 3323 I-treatment
, 49 50 3323 3324 O
a 51 52 3325 3326 O
magnetic 53 61 3327 3335 B-treatment
resonance 62 71 3336 3345 I-treatment
imaging 72 79 3346 3353 I-treatment
( 80 81 3354 3355 I-treatment
MRI 81 84 3355 3358 I-treatment
) 84 85 3358 3359 I-treatment
or 86 88 3360 3362 O
CT 89 91 3363 3365 B-treatment
of 92 94 3366 3368 I-treatment
the 95 98 3369 3372 I-treatment
abdomen 99 106 3373 3380 I-treatment
and 107 110 3381 3384 I-treatment
pelvis 111 117 3385 3391 I-treatment
and 118 121 3392 3395 O
a 122 123 3396 3397 O
chest 124 129 3398 3403 B-treatment
x 130 131 3404 3405 I-treatment
- 131 132 3405 3406 I-treatment
ray 132 135 3406 3409 I-treatment
confirming 136 146 3410 3420 O
no 147 149 3421 3423 O
evidence 150 158 3424 3432 O
of 159 161 3433 3435 O
metastatic 162 172 3436 3446 B-cancer
disease 173 180 3447 3454 I-cancer
is 181 183 3455 3457 O
acceptable 184 194 3458 3468 O

child 0 5 3469 3474 O
must 6 10 3475 3479 O
agree 11 16 3480 3485 B-contraception_consent
to 17 19 3486 3488 I-contraception_consent
use 20 23 3489 3492 I-contraception_consent
at 24 26 3493 3495 I-contraception_consent
least 27 32 3496 3501 I-contraception_consent
one 33 36 3502 3505 I-contraception_consent
form 37 41 3506 3510 I-contraception_consent
of 42 44 3511 3513 I-contraception_consent
birth 45 50 3514 3519 I-contraception_consent
control 51 58 3520 3527 I-contraception_consent
during 59 65 3528 3534 O
the 66 69 3535 3538 O
study 70 75 3539 3544 O
and 76 79 3545 3548 O
for 80 83 3549 3552 O
3 84 85 3553 3554 B-upper_bound
months 86 92 3555 3561 I-upper_bound
after 93 98 3562 3567 I-upper_bound
stopping 99 107 3568 3576 O
all 108 111 3577 3580 O
study 112 117 3581 3586 B-treatment
treatment 118 127 3587 3596 I-treatment

female 0 6 3597 3603 B-gender
participants 7 19 3604 3616 I-gender
are 20 23 3617 3620 O
advised 24 31 3621 3628 O
to 32 34 3629 3631 O
not 35 38 3632 3635 O
become 39 45 3636 3642 O
pregnant 46 54 3643 3651 B-pregnancy
during 55 61 3652 3658 O
study 62 67 3659 3664 O
participation 68 81 3665 3678 O

